These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 6147320

  • 1. Dose-response relationship of prizidilol hydrochloride (SK&F 92657): a comparison between acute and chronic effects in patients with essential hypertension.
    Pedrinelli R, Abdel-Haq B, Magagna A, Leto di Priolo S, Simonini N, Salvetti A.
    Int J Clin Pharmacol Res; 1984; 4(2):155-63. PubMed ID: 6147320
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular response to mental stress: dynamic and isometric exercise in hypertensive patients treated with prizidilol hydrochloride (SK&F 92657).
    Costa FV, Borghi C, Boschi S, Ambrosioni E.
    Int J Clin Pharmacol Res; 1984; 4(5):373-9. PubMed ID: 6151553
    [Abstract] [Full Text] [Related]

  • 3. Changes in blood pressure, fluid volumes and glomerular filtration rate during long-term treatment with prizidilol, an antihypertensive drug with combined vasodilatator and beta-adrenoceptor blocking actions.
    Andersen GS, Hartling OJ, Hein HO, Leth A.
    Dan Med Bull; 1985 Oct; 32(5):280-3. PubMed ID: 2865088
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antihypertensive effect of prizidilol.
    Andrén L, Hansson L, Svensson A.
    J Cardiovasc Pharmacol; 1983 Oct; 5(5):898-900. PubMed ID: 6195483
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive effect of prizidilol.
    Jounela AJ, Honkala M, Huikuri H.
    Ann Clin Res; 1984 Oct; 16(3):176-80. PubMed ID: 6383185
    [Abstract] [Full Text] [Related]

  • 7. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
    Eggertsen R.
    Acta Med Scand Suppl; 1984 Oct; 689():1-46. PubMed ID: 6151343
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [Abstract] [Full Text] [Related]

  • 10. Prizidilol (SK & F 92657), a new vasodilator with beta-blocking properties in the treatment of essential hypertension.
    Lüscher T, Havelka J, Greminger P, Tuma J, Täuber M, Siegenthaler W, Vetter W.
    Eur J Clin Pharmacol; 1982 Sep; 23(5):411-5. PubMed ID: 6129980
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM, Rabot D, Herrero G.
    J Cardiovasc Pharmacol; 1990 Sep; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [Abstract] [Full Text] [Related]

  • 13. Prizidilol, a combined vasodilatory and beta-adrenoceptor blocking drug, in primary hypertension. A long-term efficacy, tolerance and pharmacokinetic study.
    Karlberg BE, Larsson R, Ohman KP, Norlander B, Wirsen A, Hed J, Lundh BL, Flock A.
    Eur J Clin Pharmacol; 1983 Sep; 25(2):179-86. PubMed ID: 6138257
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical pharmacology and pharmacokinetics of prizidilol in hypertensive patients.
    Chaignon M, Decourt S, Guelpa G, Rocher I, Flouvat B, Guédon J.
    J Cardiovasc Pharmacol; 1983 Sep; 5(6):1068-73. PubMed ID: 6196556
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pulmonary effects in man of oral prizidilol hydrochloride (SK&F 92657), a new antihypertensive agent.
    Edmondstone WM, Waller JF, Manghani KK, Hill PL, Bell AJ, Denison DM.
    Br J Clin Pharmacol; 1983 Dec; 16(6):591-8. PubMed ID: 6140939
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.